Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

MediciNova- Inc. (MNOV)

8.61 0.05 (0.58%)

06-22 16:00

Open:

8.61

Pre. Close:

8.56

High:

8.98

Low:

8.4

Volume:

437,970

Market Cap:

354M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.963 - 9

9 - 9.037

Low:

8.315 - 8.351

8.351 - 8.388

Close:

8.55 - 8.614

8.614 - 8.679

Technical analysis  (as of: 2018-06-22 4:32:47 PM)

Overall:

      

Stoxline posted a BUY today, downgraded from strong buy. But this stock still is very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 11.06     One year: 12.00

Support:

Support1: 8.18    Support2: 6.81

Resistance:

Resistance1: 9.47    Resistance2: 10.27

Pivot:

8.86

Moving Averages:

MA(5): 8.49     MA(20): 8.99

MA(100): 10.79     MA(250): 8.01

MACD:

MACD(12,26): -0.47     Signal(12,26,9): -0.49

%K %D:

%K(14,3): 26.78     %D(3): 21.26

RSI:

RSI(14): 32.43

52-Week:

High: 14.5  Low: 4.4  Change(%): 57.7

Average Vol(K):

3-Month: 18600  10-Days 10171

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
MNOV has closed above bottom band by 32.7%. Bollinger Bands are 44.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to MNOV's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-02T10:47:42-04:00
Cirius Therapeutics completes enrollment in mid-stage study of lead candidate in NASH

2018-04-23T13:40:29-04:00
Biotech Forum: The Week Ahead

2018-04-19T12:04:52-04:00
Q2 2018 Biotech Catalyst Watchlist: Phase 2 Clinical Trials

2018-04-17T08:00:00-04:00
3 Things In Biotech, April 16: Liver, Liver, And More Liver

2018-04-16T08:00:00-04:00
Your Daily Pharma Scoop: Intercept's OCA, MediciNova In NASH, Pulse Biosciences Data

2018-04-13T09:56:25-04:00
Key events next week - healthcare

2018-04-13T07:03:34-04:00
MediciNova's tipelukast shows treatment effect in mid-stage NASH/NAFLD study; shares up 8% premarket

2018-04-05T08:16:00-04:00
3 Things In Biotech, April 4: Olaparib To Europe Again

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

41.13

Shares Float (M)

39.22

% Held by Insiders

% Held by Institutions

18.30

Shares Short (K)

3473

Shares Short Prior Month (K)

2380

Stock Financials

EPS

-0.280

EPS Est. Current Year

-0.350

EPS Est. Next Year

-0.340

EPS Est. Next Quarter

1.860

Forward EPS

-1.150

Book Value (p.s.)

4.640

PEG Ratio

-1.10

Profit Margin

Operating Margin

Return on Assets (ttm)

-23.3

Return on Equity (ttm)

-25.1

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.313

Qtrly Earnings Growth

Operating Cash Flow (M)

-6.92

Levered Free Cash Flow (M)

-2.11

atoplab.com

Valuation

P/E

-30.75

P/E Growth Ratio

0.01

P/BV

1.86

P/S

P/CF

-51.17

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.